Control of replicative life span in human cells: Barriers to clonal expansion intermediate between M1 senescence and M2 crisis

Molecular and Cellular Biology

Volumn 19, Issue 4, 1999, Pages 3103-3114

  Bond, J A ^a   Haughton, M F ^a   Rowson, J M ^a   Smith, P J ^a   Gire, V ^a   Wynford Thomas, D ^a   Wyllie, F S ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL AGING; CELL DIVISION; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; LIFESPAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; TUMOR SUPPRESSOR GENE; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0032912802     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.4.3103     Document Type: Article

References (54)

1. Afshari, C. A., P. J. Vojta, L. A. Annab, P. A. Futreal, T. B. Willard, and J. C. Barrett. 1993. Investigation of the role of G1/S cell cycle mediators in cellular senescence. Exp. Cell Res. 209:231-237.
2. Alcorta, D. A., Y. Xiong, D. Phelps, G. Hannon, D. Beach, and J. C. Barrett. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93:13742-13747.
3. Atadja, P., H. Wong, I. Garkavtsev, C. Geillette, and K. Riabowol. 1995. Increased activity of p53 in senescing fibroblasts. Proc. Natl. Acad. Sci. USA 92:8348-8352.
4. Bacchetti, S. 1996. Telomere dynamics and telomerase activity in cell senescence and cancer. Cell Dev. Biol. 7:31-39.
5. Banks, L., G. Matlashewski, and L. Crawford. 1986. Isolation of human p53 specific monoclonal antibodies and their use in the study of human p53 expression. Eur. J. Biochem. 159:529-534.
6. ARF links the tumor suppressors Rb and p53. Nature 395:124-125.
7. Bond, J., T. Dawson, N. R. Lemoine, and D. Wynford-Thomas. 1992. Effect of serum growth factors and phorbol ester on growth and survival of human thyroid epithelial cells expressing mutant ras. Mol. Carcinog. 5:129-135.
8. Bond, J., M. Haughton, J. Blaydes, V. Gire, D. Wynford-Thomas, and F. Wyllie. 1996. Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene 13:2097-2104.
9. Bond, J. A., F. S. Wyllie, J. Rowson, A. Radulescu, and D. Wynford-Thomas. 1994. In vitro reconstruction of tumour initiation in a human epithelium. Oncogene 9:281-290.
10. Bond, J. A., J. P. Blaydes, J. Rowson, M. F. Haughton, J. R. Smith, D. Wynford-Thomas, and F. S. Wyllie. 1995. Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SD11/WAF1. Cancer Res. 55:2404-2409.
11. Bond, J. A., F. S. Wyllie, and D. Wynford-Thomas. 1994. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9:1885-1889.
12. Bond, J. A., G. O. Ness, J. Rowson, M. Ivan, D. White, and D. Wynford-Thomas. 1996. Spontaneous de-differentiation correlates with extended lifespan in transformed thyroid epithelial cells: an epigenetic mechanism of tumour progression. Int. J. Cancer 67:563-572.
13. Brown, J. P., W. Wenyi, and J. M. Sedivy. 1997. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277:831-834.
14. Bryan, T. M., and R. R. Reddel. 1994. SV40-induced immortalization of human cells. Crit. Rev. Oncog. 5:331-357.
15. Bryan, T. M., A. Englezou, J. Gupta, S. Bacchetti, and R. R. Reddel. 1995. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:4240-4248.
16. Cristofalo, V. J., and R. J. Pignolo. 1993. Replicative senescence of human fibroblast-like cells in culture. Physiol. Rev. 73:617-638.
17. Demers, G. W., C. L. Halbert, and D. A. Galloway. 1994. Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology 198:169-174.
18. Dimri, G. P., X. Lee, G. Basile, M. Acosta, G. Scott, C. Roskelley, E. E. Medrano, M. Linskens, I. Rubelj, O. Pereira-Smith, M. Peacocke, and J. Campisi. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363-9367.
19. Filatov, L., V. Golubovskaya, J. C. Hurt, L. L. Byrd, J. M. Phillips, and W. K. Kaufmann. 1998. Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein. Oncogene 16:1825-1838.
20. Foster, S. A., and D. A. Galloway. 1996. Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene 12:1773-1779.
21. Foster, S. A., D. J. Wong, M. T. Barrett, and D. A. Galloway. 1998. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol. 18:1793-1801.
22. Funk, J. O., S. Waga, J. B. Harry, E. Espling, B. Stillman, and D. A. Galloway. 1997. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11:2090-2100.
23. Gire, V., and D. Wynford-Thomas. 1998. Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol. Cell. Biol. 18:1611-1621.
24. Gruis, N. A., P. A. van der Velden, K. A. Sandkuijl, D. E. Prins, J. Weaver-Feldhaus, A. Kamb, W. Bergman, and R. R. Frants. 1995. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat. Genet. 10:351-353.
25. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:473-478.
26. Harlow, E., L. V. Crawford, D. C. Pim, and N. M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39:861-869.
27. Hayflick, L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37:614-636.
28. Hickman, E. S., S. Bates, and K. H. Vousden. 1997. Perturbation of the p53 response by human papillomavirus type 16 E7. J. Virol. 71:3710-3718.
29. Hupp, T. R., A. Sparks, and D. P. Lane. 1995. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83:237-245
30. Jones, C. J., and D. Wynford-Thomas. Unpublished data.
31. Cip-1-mediated inhibition of cdk2. Genes Dev. 11:2101-2111.
32. Li, Y., M. A. Nichols, J. W. Shay, and Y. Xiong. 1994. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product, pRb. Cancer Res. 54:6078-6082.
33. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature 375:503-506.
34. McConnell, B. B., M. Starborg, S. Brookes, and G. Peters. 1998. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol. 8:351-354.
35. Medcalf, A. S. C., A. J. P. Klein-Szanto, and V. J. Cristofalo. 1996. Expression of p21 is not required for senescence of human fibroblasts. Cancer Res. 56:4582-4585.
36. Morgenbesser, S. D., B. O. Williams, T. Jacks, and R. A. dePinho. 1994. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72-74.
37. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
38. Pan, H., and A. E. Griep. 1994. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumour suppressor gene function in development. Genes Dev 8:1285-1299.
39. Peters, G. Personal communication.
40. Puthenveettil, J. A., S. M. Frederickson, and C. A. Reznikoff. 1996. Apoptosis in human papillomavirus 16 E7-, but not E6-immortalized human uroepithelial cells. Oncogene 13:1123-1131.
41. INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol. Cell. Biol. 15:4745-4753.
42. Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
43. Shay, J. W., W. E. Wright, D. Brasiskyte, and B. A. Van der Hagen. 1993. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalisation in human mammary epithelial cells but not human fibroblasts. Oncogene 8:1407-1413.
44. Vaziri, H., M. D. West, R. C. Allsopp, T. S. Davison, Y.-S. Wu, C. H. Arrowsmith, G. G. Poirier, and S. Benchimol. 1997. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly (ADP-ribose) polymerase. EMBO J. 16:6018-6033.
45. Vogt, M., C. Haggblom, J. Yeargin, T. Christiansen-Weber, and M. Haas. 1998. Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ. 9:139-146.
46. Vojtesek, B., J. Bartek, C. A. Midgley, and D. P. Lane. 1992. An immunochemical analysis of the human nuclear phosphoprotein p53. J. Immunol. Methods 151:237-244.
47. White, A. E., E. M. Livanos, and T. D. Tlsty. 1994. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 8:666-677.
48. Williams, D. W., E. D. Williams, and D. Wynford-Thomas. 1988. Loss of dependence in IGF-1 for proliferation of human thyroid adenoma cells. Br. J. Cancer 57:535-539.
49. Wong, H., and K. Riabowol. 1996. Differential cdk-inhibitor gene expression in aging human diploid fibroblasts. Exp. Gerontol. 31:311-325.
50. Wright, W. E., O. M. Pereira-Smith, and J. W. Shay. 1989. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol. Cell. Biol. 9:3088-3092.
51. Wyllie, F., N. Lemoine, C. Barton, T. Dawson, J. Bond, and D. Wynford-Thomas. 1993. Direct growth stimulation of normal human epithelial cells by mutant p53. Mol. Carcinogen 7:83-88.
52. Wynford-Thomas, D. 1995. Molecular genetics of thyroid cancer. Curr. Opin. Endocr. Diabetes 2:429-436.
53. Wynford-Thomas, D. 1997. Proliferative lifespan checkpoints: cell-type specificity and influence on tumour biology. Eur. J. Cancer 33:716-726.
54. Wynford-Thomas, D., and J. P. Blaydes. 1998. The influence of cell context on the selection pressure for p53 mutation in human cancer. Carcinogen 19: 29-36.